CXorf61 is a target for T cell based immunotherapy of triple-negative breast cancer

Triple-negative breast cancer (TNBC) is a high medical need disease with limited treatment options. CD8+ T cell-mediated immunotherapy may represent an attractive approach to address TNBC. The objectives of this study were to assess the expression of CXorf61 in TNBCs and healthy tissues and to evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Paret, Claudia, Simon, Petra, Vormbrock, Kirsten, Bender, Christian, Kölsch, Anne, Breitkreuz, Andrea, Yildiz, Özlem, Omokoko, Tana, Hubich-Rau, Stefanie, Hartmann, Christoph, Häcker, Sabine, Wagner, Meike, Roldan, Diana Barea, Selmi, Abderaouf, Türeci, Özlem, Sahin, Ugur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694836/
https://www.ncbi.nlm.nih.gov/pubmed/26327325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694836/
https://www.ncbi.nlm.nih.gov/pubmed/26327325

Ejemplares similares